creators_name: Uneke, Chigozie
creators_name: Ogbu, Ogbonnaya
creators_name: Alo, Moses
creators_name: Ariom, Thaddeus
creators_id: Uneke CJ
creators_id: Ogbu O
creators_id: Alo M
creators_id: Ariom T
editors_name: Kakkilaya, Srinivas
editors_name: Baliga, Shatharam
editors_id: Kakkilaya BS
editors_id: Baliga BS
type: journale
datestamp: 2006-09-25
lastmod: 2011-03-11 08:56:36
metadata_visibility: show
title: Syphilis serology in HIV-positive and HIV-negative Nigerians: The public health significance
ispublished: pub
subjects: OJHAS
full_text_status: public
keywords: Syphilis, Treponema pallidum, HIV, Seroprevalence
abstract: Syphilis has acquired new potential for morbidity and mortality through association with increased risk for HIV infection. Case-control survey was conducted using Rapid Plasma Reagin test and confirmatory Immunochromatographic test among HIV-positive (cases) and HIV-negative (control) Nigerians. A total of 35(14.0%)  of  250 HIV-positive  and 5(2.0%) of 250 HIV-negative individuals studied were seropositive for syphilis, the difference was statistically significant (P<0.05). The prevalence was higher among females than males of HIV-positive (15.0% versus 12.7%) and of the HIV-negative (2.1% versus 1.9%) individuals. Syphilis seroprevalence was highest among HIV-positive individuals aged 21-30 years (20.5%) and 41-50 years old HIV-negative individuals (4.5%). Sex education, promotion of safer sexual behaviour, prompt diagnosis of STDs and provision of effective, accessible treatment are recommended
date: 2006-09
date_type: published
publication: Online Journal Of Health And Allied Sciences
volume: 5
number: 2
publisher: Dr. B.S. Kakkilaya
refereed: TRUE
referencetext: 1.	World Health Organization (WHO). Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates. Geneva:World Health Organization;  2001. 
2.	Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet. 1998;351:5-7. 
3.	Zeltser R,  Kurban AK. Syphilis. Clin Dermatol. 2004;22:461-468. 
4.	Tramont EC. Syphilis in adults: From Christopher Columbus to Sir Alexander Fleming to  AIDS. Clin Infect Dis. 1995;21:1361-1369. 
5.	Johns DR, Tierney  M, Felsenstein  D. Alteration in the natural history of  neurosyphilis  by  concurrent infection with the human immunodeficiency virus. N Engl J Med. 1987;316:1569-1572. 
6.	O'Mahony C, Rodgers CA, Mendelsohn SS, et al. Rapidly progressive syphilis in early HIV infection. Int J Sex Trans Dis AIDS. 1997;8:275-277. 
7.	Bolan G. Syphilis and HIV. HIV InSite Knowledge Base Chapter. 1998. Available at: http://hivinsite.ucsf.edu/InSite?page=kb-05&doc=kb-05-01-04.   Accessed February 5, 2006. 
8.	Wasserheit JN. Epidemiological synergy: Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992;19:61-77. 
9.	Schmid G. Economic and programmatic aspects of congenital syphilis prevention. Bull WHO. 2004;82:402-409. 
10.	World Health Organization (WHO). AIDS epidemic update. Geneva: UNAIDS/WHO; 2004. 
11.	Ministry of Health South Africa (MOHSA). National HIV and Syphilis Sero-Prevalence Survey of Women attending Public Antenatal Clinics in South Africa. Johannesburg: MOHSA; 2001. 
12.	Federal Ministry of Health Nigeria (FMOHN). Technical report on 2001 national HIV/syphilis sentinel survey among pregnant women attending antenatal clinics in Nigeria. Abuja: FMOHN; 2004. 
13.	Tsegaye A, Rinke de Wit TF, Mekonnen Y, et al.  Decline in the prevalence of HIV- infection and  syphilis among women attending antenatal care clinic in Addis Ababa, Ethiopia: Results from sentinel surveillance, 1995-2001. J Acquir Immune Syndr. 2002;30:359-362 
14.	United Nations System in Nigeria (UNSN). Nigerian Common Country Assessment.Geneva: World Health Organization; 2001. 
15.	Cheesbrough M. District Laboratory Practice in Tropical Countries. Part 2. Cambridge University Press;  2000. 
16.	U.S. Preventive Services Task Force (USPSTF). Screening for Syphilis: Brief Update. Agency for Healthcare Research and Quality, Rockville, MD. 2004. Available at: http://www.ahrq.gov/clinic/3rduspstf/syphilis/syphilup.htm. Accessed February 5, 2006. 
17.	Hart G. Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med. 1986;104:368-376. 
18.	Dorigo-Zetsma  JW, Belewu D, Meless H, et al. Performance of routine syphilis serology in the Ethiopian cohort on HIV/AIDS. Sex Transm Infect. 2004;80:96-99. 
19.	Golden MR, Marra CM, Holmes KK. Update on syphilis: Resurgence of an old problem. JAMA. 2003;290:1510-1514. 
20.	Rodriguez I, Rodriguez ME, Fernandez C, et al. Serological diagnosis of syphilis in Cuban HIV/AIDS patients. Rev Cubana Med Trop. 2004;56:67-69. 
21.	Bowen DL, Lane HC, Fauci AS. Immunopathogenesis of the acquired immunodeficiency syndrome. Ann Intern Med. 1985;103:704-709. 
22.	Uneke CJ, Ogbu O, Inyama PU, et al. Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria Mem Inst Oswaldo Cruz. 2005;100:13-16. 
23.	Nusbaum MR, Wallace RR, Slatt LM, et al. Sexually transmitted infections and  increased risk of co-infection with human immunodeficiency virus. J Am Osteopathol Assoc. 2004;104: 527-35. 
24.	Rompalo AM, Cannon RO, Quinn TC, et al. Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis. 1992;165:1124-1126. 
25.	Young H. Syphilis: new diagnostic directions [editorial review]. International J Sex Transm Dis AIDS. 1992;3:391-413. 
26.	Augenbraun MH, DeHovitz JA, Feldman J. Biologic false-positive syphilis test results for women infected with human immunodeficiency virus. Clin Infect Dis. 1994;19:1040– 1044. 
27.	Erbelding EJ, Vlahov D, Nelson KE, et al. Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. J Infect Dis.1997;176:1397–1400. 
28.	Centers for Disease Control and Prevention (CDC). National Center for HIV, and TB Prevention, Prevention DoS. Sexually transmitted disease surveillance 2001 supplement: Syphilis surveillance report. Atlanta, GA: Department of Health and Human Services; 2003. 
29.	Hwang LY, Ross MW, Zack C, et al.  Prevalence of STIs  and association risk factors among  population of drug abuse. J Clin Infect. 2000;319:920-926. 
30.	Todd J, Muguti K, Grosskurlt H, et al. Risk factors for active syphilis and TPHA seroconversion in a rural Africa population. J Sex Transm Infect. 2001;7:37-45. 
31.	Gourevitch  MN, Hartel D, Schenbaum EE, et al. A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx. Am J Pub Health. 1996;86:1112- 1115. 
32.	World Health Organization (WHO). The World Health Report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization; 2002. 
33.	International Development Research Centre (IDRC). Population and Health in Developing Countries, Vol 1. Ottawa: Population health and survival at INDEPTH sites; 2002.
citation:   Uneke Jesse, Chigozie and Ogbu, Ogbonnaya and Alo, Moses and Ariom, Thaddeus  (2006) Syphilis serology in HIV-positive and HIV-negative Nigerians: The public health significance.  [Journal (On-line/Unpaginated)]     
document_url: http://cogprints.org/5169/1/2006-2-5.pdf